Plandaí Biotechnology, Inc. (OTCPK: PLPL)
Health Care · Biotechnology · TW
$0.00
-99.00% today · 0.0% 1Y
Plandaí Biotechnology, Inc. (OTCPK: PLPL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $44.89K and employs 180 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Plandaí Biotechnology, Inc. across four factors: quality 8/100, value 38/100. Its strongest factor is value.
PLPL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.89K
- Revenue (TTM)
- $338.48K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 30.85
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 44.89B
- Employees
- 180
- Next earnings
- —
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. specializes in developing distinctive botanical extracts intended for the nutriceutical and pharmaceutical industries. A primary focus is the development of its Phytofare Catechin Complex, an extract originating from green tea cultivated at the Senteeko Tea Estate in Mpumalanga, South Africa. The company is also advancing its Phytofare citrus complex, a citrus-based extract, alongside extracts derived from tomato fruit, Artemisia, and cannabis. Beyond its biotechnological pursuits, Plandaí operates agricultural holdings in South Africa, where it produces and sells timber and various other farm products. The company's corporate base is in London, United Kingdom.
- ISIN
- US72703D1000
- Listed since
- Feb 2, 1995
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.